As the cannabis market has started to recover amidst the COVID-19 pandemic, investors are looking at where the market can grow. One leading candidate is cannabinoid production. THC, CBD, and other specific cannabinoids can be useful for a variety of treatments, includ...
Omri Wallach
|
June 9, 2020
|
(Click image to play video) Avicanna Inc. ( TSX: AVCN , OTCQX: AVCNF , Forum ) is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products...
Featured Submission
|
April 20, 2021
|
(Click image to play video) Get to know Toronto-based Avicanna Inc. (AVCN) ( TSX.AVCN , OTC: AVCNF , Forum ) – a biopharmaceutical company developing and driving biopharmaceutical advancements of plant-derived cannabinoid-based products, and the man at the h...
Dave Jackson
|
May 6, 2021
|
InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. Vancouver-based clinical stage biopharmaceutical company InMed Pharmaceuticals Inc. (IN:TSX; IMLFF:OTCQX) , which is engaged in...
Streetwise Reports
|
January 21, 2020
|
This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
Stockhouse Media
|
November 6, 2019
|
FSD Pharma Inc. ( CSE: HUGE , OTCQB: FSDDF , Forum ) is focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the deve...
Stockhouse Media
|
October 23, 2019
|
An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...
Isabella Zavarise
|
December 22, 2020
|
PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...
Featured Submission
|
March 9, 2021
|
At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis
|
November 12, 2019
|
Steve DeAngelo chats with Cindy Broad for the Arcview 2020 Vision Series First Forum: Cannabis Investing for a New Decade. Listen to Steve's colourful commentary on everything from surviving the dip, to what's next for the industry, to his views on psychedelics......
Cindy Broad
|
February 11, 2020
|